Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06224127Phase 1Not yet recruiting
Phase 1, randomised, single-blind trial (3 arms), sponsored by Soovu Labs. Primary endpoints: Anxiety rating (VAS-A) at 90 months, Anxiety level (PROMIS anxiety short form) at 90 months and 1 more. Planned start Jul 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06224127.